{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33571758",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.mehy.2021.110508",
      "S0306-9877(21)00026-8"
    ],
    "Journal": {
      "ISSN": "1532-2777",
      "JournalIssue": {
        "Volume": "148",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "Medical hypotheses",
      "ISOAbbreviation": "Med Hypotheses"
    },
    "ArticleTitle": "Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?",
    "Pagination": {
      "StartPage": "110508",
      "MedlinePgn": "110508"
    },
    "Abstract": {
      "AbstractText": [
        "Several studies have reported that certain psychoactive drugs could have a protective effect against SARS-CoV-2. Herein, we propose that antihistamines (anti-H1) and cationic amphiphilic drugs (CAD), specifically, have the capacity to disrupt virus entry and replication. In addition, several of these molecules have limited side effects and as such could be promising prophylactic candidates against SARS-CoV-2 infection."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Psychiatry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil; Clinique de Psychiatrie, CHU de Strasbourg, France."
          }
        ],
        "LastName": "Gitahy Falcao Faria",
        "ForeName": "Clara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinique de Psychiatrie, CHU de Strasbourg, France."
          }
        ],
        "LastName": "Weiner",
        "ForeName": "Luisa",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratoire Synth\u00e8se et Isolement de Mol\u00e9cules BioActives (SIMBA, EA 7502), Universit\u00e9 de Tours, Facult\u00e9 des Sciences et Techniques, Tours, France."
          }
        ],
        "LastName": "Petrignet",
        "ForeName": "Julien",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00f4le Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychoth\u00e9rapique de Nancy, Laxou, CHU de Nancy, D\u00e9partement de Neurologie, Nancy, France."
          }
        ],
        "LastName": "Hingray",
        "ForeName": "Coraline",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Donostia University Hospital,Donostia, Guip\u00fazcoa, Spain."
          }
        ],
        "LastName": "Ruiz De Pellon Santamaria",
        "ForeName": "\u00c1ngel",
        "Initials": "\u00c1"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Paris, NeuroDiderot, Inserm U1141, h\u00f4pital Robert-Debr\u00e9, F-75019 Paris, France."
          }
        ],
        "LastName": "Villoutreix",
        "ForeName": "Bruno O",
        "Initials": "BO"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Inserm U 1138 Centre de recherche des Cordeliers 75006 Paris, Universit\u00e9 de Paris, Paris, France."
          }
        ],
        "LastName": "Beaune",
        "ForeName": "Philippe",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris Est Cr\u00e9teil (UPEC), INSERM U955, IMRB, Laboratoire Neuro-psychiatrie translationnelle, AP-HP, D\u00e9partement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU ADAPT), H\u00f4pital Henri Mondor, Fondation FondaMental, F-94010 Cr\u00e9teil, France."
          }
        ],
        "LastName": "Leboyer",
        "ForeName": "Marion",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Etablissement Public de Sant\u00e9 Alsace Nord, Brumath, France Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Universit\u00e9 de Strasbourg, Strasbourg, France. Electronic address: herve.javelot@ch-epsan.fr."
          }
        ],
        "LastName": "Javelot",
        "ForeName": "Herv\u00e9",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Med Hypotheses",
    "NlmUniqueID": "7505668",
    "ISSNLinking": "0306-9877"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine H1 Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Surface-Active Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Histamine H1 Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Surface-Active Agents"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Replication"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}